Amicus Therapeutics, Inc. Stock Performance
as on October 20, 2025 at 10:38 pm IST
Day's Low
Day's High
$8.09$8.53
5.27%
Downside
-0.12%
Upside
52 Week's Low
52 Week's High
$5.51$12.6535.48%
Downside
48.13%
Upside
Amicus Therapeutics, Inc. share price movements today
- Previous Close
- $8.04
- Open
- $8.12
- Volume
- 7.5M
- Day's Low - High
- $8.09 - $8.53
- 52 Week Low - High
- $5.51 - $12.65
Amicus Therapeutics, Inc. Historical Returns
- 1 Month Return
- -3.48 %
- 3 Month Return
- + 34.9 %
- 1 Year Return
- -32.44 %
- 3 Year Return
- -25.76 %
- 5 Year Return
- -52.64 %
Amicus Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Amicus Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.3B
EPS (TTM)
0.3236
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-28.04
Industry PE ratio
8.355964912280701
PEG Ratio
-0.18
EBITDA
32.9M
Revenue (TTM)
571.2M
Profit Margin
-6.67%
Return On Equity TTM
45636400.00%
Amicus Therapeutics, Inc. Stock Valuation
Track how Amicus Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Amicus Therapeutics, Inc. in the last 5 years
Lowest (-74.24x)
December 31, 2024
Today (-28.04x)
October 20, 2025
Industry (8.36x)
October 20, 2025
Highest (185.08x)
March 31, 2025
Today’s Price to Earnings Ratio: -28.04x
Amicus Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Amicus Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.3B | -52.64% | -28.04 | -6.67% | |
| BUY | $63.1B | 240.52% | -505.15 | -12.96% | |
| NA | $35.3B | NA | NA | -3.89% | |
| BUY | $106.9B | 94.28% | 29.67 | 31.86% | |
| BUY | $61.3B | 0.25% | 14.58 | 31.37% |
Stock Returns calculator for Amicus Therapeutics, Inc. Stock including INR - Dollar returns
The Amicus Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amicus Therapeutics, Inc. investment value today
Current value as on today
₹76,495
Returns
Returns from Amicus Therapeutics, Inc. Stock
Dollar Returns*
₹4,730 (+4.73%)
Analyst Recommendation on Amicus Therapeutics, Inc. Stock
Based on 17 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 17 analysts, 76.47% of analysts recommend a 'BUY' rating for Amicus Therapeutics, Inc.. Average target price of $16.09
Amicus Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Amicus Therapeutics, Inc..
What analysts predicted
46.92%UPSIDE
Target Price
$16.09
Current Price
$8.54
Analyzed by
17 Analysts
Target
$16.09
Amicus Therapeutics, Inc. target price $16.09, a slight upside of 46.92% compared to current price of $8.54. According to 17 analysts rating.
Amicus Therapeutics, Inc. Stock’s Investor Sentiment and Interest
Search interest for Amicus Therapeutics, Inc. Stock has increased by 91% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:91% versus previous 30 day period
Amicus Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Amicus Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Amicus Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Amicus Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Amicus Therapeutics, Inc. News & Key Events
Today's Timeline - 07 October
Tue, 09:30 PM
-Amicus Therapeutics maintains Zacks Rank #1; 2025 earnings estimates steady at 31 cents.
Insights on Amicus Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 125.24M → 154.68M (in $), with an average increase of 19.0% per quarter
- POSITIVE IMPACT
Price Rise
In the last 3 months, FOLD stock has moved up by 34.9%
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.8% return, outperforming this stock by 95.2%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 149.6% return, outperforming this stock by 175.4%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 14.73M → -24.42M (in $), with an average decrease of 129.9% per quarter
About Amicus Therapeutics, Inc.
| Organisation | Amicus Therapeutics, Inc. |
| Headquarters | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
| Industry | Health Technology |
| CEO | Mr. Bradley L. Campbell M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Amicus Therapeutics, Inc.
Name | Title |
|---|---|
Dr. Jeffrey P. Castelli Ph.D. | Chief Development Officer |
Mr. Andrew Faughnan | Vice President of Investor Relations |
Mr. Bradley L. Campbell M.B.A. | CEO, President & Director |
Mr. Simon Nicolas Reade Harford | Chief Financial Officer |
Ms. Ellen S. Rosenberg J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Patrik S. Florencio Esq. | Global Chief Compliance & Risk Officer |
Ms. Diana Moore | Head of Global Corporate Communications |
Mr. David M. Clark | Chief People Officer |
Ms. Samantha L. Prout | Chief Accounting Officer & Controller |
Dr. Jill Weimer Ph.D. | Chief Science Officer |
FAQs
What is Amicus Therapeutics, Inc. share price today?
Amicus Therapeutics, Inc. share price today is $8.54 as on . Amicus Therapeutics, Inc. share today touched a day high of $8.53 and a low of $8.09.
What is the 52 week high and 52 week low for Amicus Therapeutics, Inc. share?
Amicus Therapeutics, Inc. share touched a 52 week high of $12.65 on and a 52 week low of $5.51 on . Amicus Therapeutics, Inc. stock price today i.e. is trending at $8.54,which is 32.49% down from its 52 week high and 54.99% up from its 52 week low.
What is Amicus Therapeutics, Inc.'s market capitalisation today?
Amicus Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Amicus Therapeutics, Inc. Stock (FOLD) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Amicus Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amicus Therapeutics, Inc. Shares that will get you 0.1756 shares as per Amicus Therapeutics, Inc. share price of $8.54 per share as on October 20, 2025 at 10:38 pm IST.
What is the minimum amount required to buy Amicus Therapeutics, Inc. Stock (FOLD) from India?
Indian investors can start investing in Amicus Therapeutics, Inc. (FOLD) shares with as little as ₹87.9 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹879.00 in Amicus Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amicus Therapeutics, Inc. share’s latest price of $8.54 as on October 20, 2025 at 10:38 pm IST, you will get 1.1710 shares of Amicus Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Amicus Therapeutics, Inc. has given to Indian investors in the last 5 years?
Amicus Therapeutics, Inc. stock has given -52.64% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?